- Home
- EDIT vs YSG Comparison
EDIT vs YSG Comparison
Compare EDIT & YSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EDIT | YSG |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.9M | 267.5M |
| IPO Year | 2016 | 2020 |
Fundamental Metrics
Financial Performance| Metric | EDIT | YSG |
|---|---|---|
| Price | $2.91 | $2.77 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.30 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 91.7K |
| Earning Date | 05-11-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.50 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $31,937,000.00 | N/A |
| Revenue This Year | N/A | $23.08 |
| Revenue Next Year | N/A | $9.45 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 132.64 | N/A |
| 52 Week Low | $1.43 | $2.64 |
| 52 Week High | $4.54 | $11.04 |
Technical Indicators
Market Signals| Indicator | EDIT | YSG |
|---|---|---|
| Relative Strength Index (RSI) | 48.07 | 37.09 |
| Support Level | $2.77 | $2.64 |
| Resistance Level | $3.17 | $3.10 |
| Average True Range (ATR) | 0.22 | 0.18 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 28.00 | 30.43 |
Price Performance
Historical ComparisonAbout EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.
About YSG Yatsen Holding Limited
Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands.